ArticleJournal of health, population, and nutrition2026
Association and predictive performance of the ZJU index for incident cardiometabolic multimorbidity in middle-aged and older adults: a 10-year prospective cohort study.
Article in Journal of health, population, and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to comprehensively examine the association between the ZJU index and the risk of developing cardiometabolic multimorbidity (CMM) among middle-aged and older Chinese adults.
methodsUtilizing data from the Guizhou sub-cohort of the REACTION study, the ZJU index was derived by integrating key metrics, including body mass index (BMI), fasting plasma glucose (FPG), triglycerides (TG), and the alanine aminotransferase to aspartate aminotransferase ratio (ALT/AST). A total of 8,797 participants aged 40 and older were monitored over an average duration of 10.05 years, with 6,854 individuals (77.9%) included in the final analysis. Participants were categorized into quartiles based on their initial ZJU Index levels. To evaluate independent associations, multivariable logistic regression was employed; restricted cubic splines (RCS) were used to illustrate dose-response relationships, and recursive algorithms were applied to determine risk thresholds. The predictive accuracy of the ZJU index was compared with traditional single indicators using receiver operating characteristic (ROC) curves.
resultThroughout the follow-up period, 381 new cases of CMM were recorded. After controlling for confounding variables, a linear positive relationship was observed between the ZJU index and CMM risk (P for non-linearity > 0.05). The highest quartile (Q4) exhibited a 2.29-fold increase in the risk of CMM (95% CI: 1.42-3.70) compared to the lowest quartile (Q1). The area under the ROC curve (AUC) for the ZJU index in predicting CMM was 0.651 (95% CI: 0.623-0.678), significantly outperforming the predictive capabilities of BMI, FPG, TG, and the ALT/AST ratio individually. Subgroup analyses revealed that this relationship remained consistent across various categories defined by sex, age, BMI, smoking status, and drinking status, with no significant interactions detected.
conclusionThe ZJU index serves as an independent risk factor for CMM. Its straightforward calculation and excellent predictive ability make it highly suitable for early screening and risk assessment in community settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.